Annie Borgne‐Sanchez

1.4k citations

22 papers · 1.1k · 1 hit paper · h-index 15

Impact in

Pharmacology top 1%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacogenetics and Drug Metabolism
Hepatology top 10%

Papers in

Clinical Biochemistry 6
- Metabolism and Genetic Disorders 6
Hepatology 4

Co-authors: Bernard Fromenty (9 shared papers)Karima Begriche (4 shared papers)Julie Massart (4 shared papers)Marie‐Anne Robin (1 shared paper)Nelly Buron (14 shared papers)Mathieu Porceddu (11 shared papers)Gilles Labbe (1 shared paper)Catherine Brenner (6 shared papers)
Journals: APOPTOSIS (2 papers)Toxicological Sciences (2 papers)Environmental Toxicology (1 paper)Biochimica et Biophysica Acta (BBA) - Bioenergetics (1 paper)Cell Biology and Toxicology (1 paper)
Partner nations: France United Kingdom United States

In The Last Decade

Annie Borgne‐Sanchez

22 papers receiving 1.1k citations

Annie Borgne‐Sanchez's Hit Papers

align trajectories log scale

Drug-induced toxicity on mitochondria and lipid metabolism: Mechanistic diversity and deleterious consequences for the liver 2010 · 448 citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2010 Journal of Hepatology

Peers

Countries citing papers authored by Annie Borgne‐Sanchez

Since Specialization

Citations

This map shows the geographic impact of Annie Borgne‐Sanchez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annie Borgne‐Sanchez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annie Borgne‐Sanchez more than expected).

Fields of papers citing papers by Annie Borgne‐Sanchez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annie Borgne‐Sanchez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annie Borgne‐Sanchez. The network helps show where Annie Borgne‐Sanchez may publish in the future.

Co-authors

The 25 scholars most cited alongside Annie Borgne‐Sanchez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Annie Borgne‐Sanchez Line = papers co-authored together Annie Borgne‐Sanchez links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Drug-induced toxicity on mitochondria and lipid metabolism: Mechanistic diversity and deleterious consequences for the liver Journal of Hepatology ·Karima Begriche, Julie Massart, Marie‐Anne Robin, Annie Borgne‐Sanchez, Bernard Fromenty Hit paper breakdown →	2010	448
2	Prediction of Liver Injury Induced by Chemicals in Human With a Multiparametric Assay on Isolated Mouse Liver Mitochondria Toxicological Sciences ·Mathieu Porceddu, Nelly Buron, Célestin Roussel, Gilles Labbe, Bernard Fromenty, Annie Borgne‐Sanchez	2012	151
3	Chemosensitization by Knockdown of Adenine Nucleotide Translocase-2 Cancer Research ·Morgane Le Bras, Annie Borgne‐Sanchez, Zahia Touat, Ossama Sharaf El Dein, Aurélien Deniaud, Evelyne Maillier, Dominique Rebouillat, Christophe Lemaire	2006	87
4	HIV-1 Tat protein directly induces mitochondrial membrane permeabilization and inactivates cytochrome c oxidase Cell Death and Disease ·Annie Borgne‐Sanchez, Olivier Chaloin, Ralph El-Khoury, Magali Brabant, Alain Langonné, Mathieu Porceddu, J-J Brière, Nelly Buron	2012	63
5	Drug-Induced Inhibition of Mitochondrial Fatty Acid Oxidation and Steatosis Current Pathobiology Reports ·Julie Massart, Karima Begriche, Nelly Buron, Mathieu Porceddu, Annie Borgne‐Sanchez, Bernard Fromenty	2013	45
6	Use of Human Cancer Cell Lines Mitochondria to Explore the Mechanisms of BH3 Peptides and ABT-737-Induced Mitochondrial Membrane Permeabilization PLoS ONE ·Nelly Buron, Mathieu Porceddu, Magali Brabant, Diana Desgué, Cindy Racoeur, Myriam Lassalle, Christine Péchoux, Pierre Rustin	2010	43
7	Targeted Vpr-derived peptides reach mitochondria to induce apoptosis of αVβ3-expressing endothelial cells Cell Death and Differentiation ·Annie Borgne‐Sanchez, Sylvain Dupont, Alain Langonné, Ludwig Baux, H Lecoeur, David Chauvier, Myriam Lassalle, Olivier Déas	2006	42
8	Drug-induced hepatic steatosis in absence of severe mitochondrial dysfunction in HepaRG cells: proof of multiple mechanism-based toxicity Cell Biology and Toxicology ·Julien Allard, Simon Bucher, Julie Massart, Pierre‐Jean Ferron, Dounia Le Guillou, Roxane Loyant, Yoann Daniel, Youenn Launay	2020	35
9	Upstream control of apoptosis by caspase-2 in serum-deprived primary neurons APOPTOSIS ·David Chauvier, Alain Langonné, Annie Borgne‐Sanchez, Jean Mariani, Jean‐Claude Martinou, Dominique Rebouillat, Etienne D. Jacotot +1 other	2005	34
10	The fourth isoform of the adenine nucleotide translocator inhibits mitochondrial apoptosis in cancer cells The International Journal of Biochemistry & Cell Biology ·Cindy Gallerne, Zahia Touat, Zhi Xiong Chen, Cécile Martel, Eléonore Mayola, Ossama Sharaf El Dein, Nelly Buron, Morgane Le Bras	2010	32
11	Adipose tissue senescence is mediated by increased ATP content after a short‐term high‐fat diet exposure Aging Cell ·Maria Silvia Pini, Gábor Czibik, Daigo Sawaki, Zaineb Mezdari, Laura Braud, Thaïs Delmont, Cécile Martel, Nelly Buron	2021	30
12	Therapeutic peptides: Targeting the mitochondrion to modulate apoptosis Biochimica et Biophysica Acta (BBA) - Bioenergetics ·Étienne Jacotot, Aurélien Deniaud, Annie Borgne‐Sanchez, Zahia Touat, J.-P. Briand, Morgane Le Bras, Catherine Brenner	2006	25
13	The Mitochondrion-lysosome Axis in Adaptive and Innate Immunity: Effect of Lupus Regulator Peptide P140 on Mitochondria Autophagy and NETosis Frontiers in Immunology ·Mykolas Bendorius, Indira Neeli, Fengjuan Wang, Srinivasa Reddy Bonam, Eszter Dombi, Nelly Buron, Annie Borgne‐Sanchez, Joanna Poulton	2018	22
14	Aftins Increase Amyloid-β42, Lower Amyloid-β38, and Do Not Alter Amyloid-β40 Extracellular Production in vitro: Toward a Chemical Model of Alzheimer's Disease? Journal of Alzheimer s Disease ·Arnaud Hochard, Nassima Oumata, Karima Bettayeb, Olfa Gloulou, Xavier Fant, Émilie Durieu, Nelly Buron, Mathieu Porceddu	2013	17
15	Chronic and low exposure to a pharmaceutical cocktail induces mitochondrial dysfunction in liver and hyperglycemia: Differential responses between lean and obese mice Environmental Toxicology ·Nelly Buron, Mathieu Porceddu, Célestin Roussel, Karima Begriche, Viviane E. Trak-Smayra, Thomas Gicquel, Bernard Fromenty, Annie Borgne‐Sanchez	2016	16
16	A flavivirus protein M-derived peptide directly permeabilizes mitochondrial membranes, triggers cell death and reduces human tumor growth in nude mice APOPTOSIS ·Magali Brabant, Ludwig Baux, Richard Casimir, Jean Paul Briand, Olivier Chaloin, Mathieu Porceddu, Nelly Buron, David Chauvier	2009	12
17	Mitochondrial dysfunction in drug-induced hepatic steatosis: Recent findings and current concept Clinics and Research in Hepatology and Gastroenterology ·Annie Borgne‐Sanchez, Bernard Fromenty	2025	8
18	Drug-Induced Mitochondrial Toxicity HAL (Le Centre pour la Communication Scientifique Directe) ·Julie Massart, Annie Borgne‐Sanchez, Bernard Fromenty	2018	7
19	Drug-induced impairment of mitochondrial fatty acid oxidation and steatosis: assessment of causal relationship with 45 pharmaceuticals Toxicological Sciences ·Nelly Buron, Mathieu Porceddu, Roxane Loyant, Cécile Martel, Julien Allard, Bernard Fromenty, Annie Borgne‐Sanchez	2024	7
20	In Vitro Assessment of Mitochondrial Toxicity to Predict Drug-Induced Liver Injury Methods in pharmacology and toxicology ·Mathieu Porceddu, Nelly Buron, Pierre Rustin, Bernard Fromenty, Annie Borgne‐Sanchez	2018	6

About Annie Borgne‐Sanchez

Annie Borgne‐Sanchez is a scholar working on Clinical Biochemistry, Hepatology, Pharmacology, Epidemiology and Physiology, having authored 22 papers that have together received 1.1k indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (7 papers), Metabolism and Genetic Disorders (6 papers), Liver Disease Diagnosis and Treatment (5 papers), Drug-Induced Hepatotoxicity and Protection (4 papers), RNA Interference and Gene Delivery (3 papers), ATP Synthase and ATPases Research (3 papers), Cell death mechanisms and regulation (2 papers) and Peroxisome Proliferator-Activated Receptors (2 papers). The work is most often cited by research in Pharmacology (289 citations), Hepatology (111 citations), Clinical Biochemistry (88 citations), Virology (44 citations) and Epidemiology (255 citations). Annie Borgne‐Sanchez has collaborated with scholars based in France, United Kingdom and United States. Frequent co-authors include Bernard Fromenty, Karima Begriche, Julie Massart, Marie‐Anne Robin, Nelly Buron, Mathieu Porceddu, Gilles Labbe, Catherine Brenner, Dominique Rebouillat and Étienne Jacotot. Their work appears in journals such as APOPTOSIS, Toxicological Sciences, Environmental Toxicology, Biochimica et Biophysica Acta (BBA) - Bioenergetics and Cell Biology and Toxicology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Annie Borgne‐Sanchez

Impact in

Papers in i

In The Last Decade

Annie Borgne‐Sanchez

Annie Borgne‐Sanchez's Hit Papers

Peers

Countries citing papers authored by Annie Borgne‐Sanchez

Fields of papers citing papers by Annie Borgne‐Sanchez

All Works

About Annie Borgne‐Sanchez

Explore authors with similar magnitude of impact

Papers in